Search
Menu
Bristol Instruments, Inc. - 872 Series LWM 10/24 LB
< More Webinar AlertsSubscribe to our E-Newsletters

Join us for a FREE webinar: "Biophotonic Tools for Diagnosing and Treating Eye Disease" (5/2/2017)

Join us for a FREE webinar: "Biophotonic Tools for Diagnosing and Treating Eye Disease"
The development of new blood vessels plays a pivotal role in the leading causes of blindness, including macular degeneration and diabetic retinopathy.
If you are having problems seeing this newsletter, please click here to view
Tuesday, May 2, 2017
        
 

Join us for a FREE Webinar

Biophotonic Tools for Diagnosing and Treating Eye Disease

Wednesday, May 17, 2017 1:00 PM - 2:00 PM

Register Now

 
About This Webinar
 
 
The development of new blood vessels plays a pivotal role in the leading causes of blindness, including macular degeneration and diabetic retinopathy. These conditions affect millions of people around the world and are rapidly increasing in prevalence. Retinal laser therapy was developed more than 50 years ago and has had a profound and lasting impact on the treatment of these diseases. Significant advances have been achieved in laser technology and the molecular understanding of laser-tissue interactions to improve diagnosis and treatment.

In this webinar, Yannis M. Paulus, M.D., will discuss novel biophotonics tools and techniques for diagnosing and treating eye diseases, including retinal laser therapies and imaging. He will present significant advances in selective, reproducible retinal laser therapy. He will also discuss Photo-Mediated Ultrasound Therapy (PUT), a novel approach using a low intensity laser concurrently with ultrasound to selectively treat blood vessels.

Dr. Paulus will also speak on new imaging modalities in ophthalmology, including optical coherence tomography, photoacoustic imaging, handheld/smartphone based imaging, and molecular imaging. He will discuss how use of these techniques and technology can enable early diagnosis of disease and improved monitoring of response to treatment.

Yannis Paulus, M.D., is an academic vitreoretinal surgeon who directs an active lab developing novel retinal imaging and treatment systems. He completed his undergraduate in chemistry and physics at Harvard University, medical school and ophthalmology residency at Stanford University and a surgical retina fellowship at Johns Hopkins University Wilmer Eye Institute. His laboratory investigates photoacoustic microscopy, molecular imaging of the retina, photo-mediated ultrasound therapy (PUT), restorative laser therapy, and smartphone-based retinal photography. He is an assistant professor of Ophthalmology and Visual Sciences and an assistant professor of Biomedical Engineering at the University of Michigan Kellogg Eye Center. Through his research, Dr. Paulus seeks to help physicians diagnose diseases earlier, improve treatment monitoring, and practice precision medicine tailored to each unique patient.
 
Mark Your Calendar
 
 

Date: Wednesday, May 17, 2017

Time: 1:00 PM - 2:00 PM

Space is limited. Reserve your Webinar seat now at: https://attendee.gotowebinar.com/register/1034147141095693827

After registering you will receive a confirmation email containing information about joining the Webinar.
 

SYSTEM REQUIREMENTS

PC-based attendees
Required: Windows® 10, 8, 7, Vista, XP or 2003 Server

Mac® -based attendees
Required: Mac OS® X 10.6 or newer

Mobile attendees
Required: iPhone® , iPad® , AndroidTM phone or tablet, Windows 8 or Windows Phone 8
 
More from Photonics Media
 
 

Upcoming Webinars

- Introduction to Machine Vision Software, Thu, May 11
- Perspectives in 3D Confocal Raman Imaging, Tue, May 30
- OLED Foldable Displays: The Future of the Display Industry, Thu, Jun 1

Archived Webinars

- Simulating Metamaterials in the Terahertz Regime
- Introducing the CAOS Smart Camera - Empowering Extreme Imaging
- Large-Scale, Deep-Tissue Neuronal Imaging
 
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.